Back to search
FDAFDA · Food and drugs·Recall number D-0490-2017

CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, Columbus, OH--- NDC 68084-921-25

Published March 8, 2017 · Recall initiated: February 8, 2017

Summary

FDA records drug Class II recall D-0490-2017, published March 8, 2017 and initiated February 8, 2017. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 454 cartons; Lot: Lot 154527, exp 4/30/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

What to do

Voluntary: Firm initiated · Letter

Get an email if CYCLOSPORINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CYCLOSPORINE
Manufacturer
Amerisource Health Services
Distributor
Nationwide
Lot
Lot 154527, exp 4/30/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, Columbus, OH--- NDC 68084-921-25 recalled?

Yes. FDA published recall D-0490-2017 on March 8, 2017. Reported hazard: Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CYCLOSPORINE.